|
|
|
|
A more recent version of this article appeared on February 1, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 7, 2004
Revised on October 12, 2004
Accepted on October 14, 2004

||¶
*Molecular Oncology Group, McGill University Health Center and Departments of
Biochemistry,
Medicine, and ||Oncology, McGill University, Montreal, Quebec, Canada H3A 1A1;
Cancer Research Institute, University of California, San Francisco/Mt. Zion Comprehensive Cancer Center, San Francisco, CA 94143-0128
Monitoring Editor: Anthony Pawson
Activation of the Hepatocyte Growth Factor receptor, Met, induces a morphogenic response and stimulates the formation of branching tubules by Madin-Darby Canine Kidney epithelial cells in three-dimensional cultures. A constitutively activated ErbB2/Neu receptor, (NeuNT), promotes a similar invasive morphogenic program in MDCK cells. Because both receptors are expressed in breast epithelia, are associated with poor prognosis and HGF is expressed in stroma, we examined the consequence of cooperation between these signals. We show that HGF disrupts NeuNT-induced epithelial morphogenesis, stimulating the breakdown of cell-cell junctions, dispersal and invasion of single cells. This correlates with a decrease in junctional proteins claudin-1 and E-cadherin, in addition to the internalization of the tight junction protein, Z0-1. HGF-induced invasion of NT-expressing cells is abrogated by pretreatment with a pharmacological inhibitor of the MEK pathway, which restores E-cadherin and ZO-1 at cell-cell junctions, establishing the involvement of MEK-dependent pathways in this process. These results demonstrate that physiological signals downstream from the HGF/Met receptor synergize with ErbB2/Neu to enhance the malignant phenotype, promoting the breakdown of cell-cell junctions and enhanced cell invasion. This is particularly important for cancers where ErbB2/Neu is overexpressed and HGF is a physiological growth factor found in the stroma.
This article has been cited by other articles:
![]() |
T. R. Graham, H. E. Zhau, V. A. Odero-Marah, A. O. Osunkoya, K. S. Kimbro, M. Tighiouart, T. Liu, J. W. Simons, and R. M. O'Regan Insulin-like Growth Factor-I-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells Cancer Res., April 1, 2008; 68(7): 2479 - 2488. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Shattuck, J. K. Miller, K. L. Carraway III, and C. Sweeney Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells Cancer Res., March 1, 2008; 68(5): 1471 - 1477. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Reznik, Y. Sang, Y. Ma, R. Abounader, E. M. Rosen, S. Xia, and J. Laterra Transcription-Dependent Epidermal Growth Factor Receptor Activation by Hepatocyte Growth Factor Mol. Cancer Res., January 1, 2008; 6(1): 139 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Eastham, H. Spencer, F. Soncin, S. Ritson, C. L.R. Merry, P. L. Stern, and C. M. Ward Epithelial-Mesenchymal Transition Events during Human Embryonic Stem Cell Differentiation Cancer Res., December 1, 2007; 67(23): 11254 - 11262. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Shattuck, J. K. Miller, M. Laederich, M. Funes, H. Petersen, K. L. Carraway III, and C. Sweeney LRIG1 Is a Novel Negative Regulator of the Met Receptor and Opposes Met and Her2 Synergy Mol. Cell. Biol., March 1, 2007; 27(5): 1934 - 1946. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Arteaga Will Single-Time Tumor Profiling and a "Guilt by Association" Approach Allow Us to Outsmart HER2-Positive Breast Cancer? Clin. Cancer Res., February 15, 2007; 13(4): 1071 - 1073. [Full Text] [PDF] |
||||
![]() |
S. Oltean, B. S. Sorg, T. Albrecht, V. I. Bonano, R. M. Brazas, M. W. Dewhirst, and M. A. Garcia-Blanco Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity PNAS, September 19, 2006; 103(38): 14116 - 14121. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Irie, R. V. Pearline, D. Grueneberg, M. Hsia, P. Ravichandran, N. Kothari, S. Natesan, and J. S. Brugge Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition J. Cell Biol., December 19, 2005; 171(6): 1023 - 1034. [Abstract] [Full Text] [PDF] |
||||